Pancreatic cancer is one of the deadliest forms of cancer, often diagnosed at an advanced stage due to its non-specific symptoms. However, a groundbreaking study led by researchers Noam Shemesh and Carlos Bilreiro has found that Diffusion Tensor Imaging (DTI), a specific type of MRI, can robustly
Artificial intelligence (AI) is dramatically revolutionizing the field of breast cancer screening and risk reduction by introducing advanced methods for analyzing mammographic images and identifying new risk predictors. With these innovations, the medical community is moving towards more
In a groundbreaking development for cancer diagnostics, researchers at the University of British Columbia have created an innovative deep learning model aimed at improving the diagnosis and treatment of pancreatic ductal adenocarcinoma (PDAC). This type of pancreatic cancer is notably the most
Recent advancements in the field of monoclonal antibody (mAb) treatments have shown a promising shift towards more effective cancer therapies. The 3E10 antibody, initially identified in autoimmune mouse studies focused on systemic lupus erythematosus, has emerged as a game-changer. Unlike
Hodgkin lymphoma, a rare but treatable blood cancer, primarily impacts younger individuals aged 20-40. Effective treatment is crucial, but so is the consideration of long-term health and quality of life for patients. Recent advancements in chemotherapy regimens have shown promise in reducing
The PROSPECT-Lung trial has officially commenced, heralding a significant advance in the quest to enhance treatment strategies for patients with resectable non-small cell lung cancer (NSCLC). This trial marks the inaugural endeavor of the newly established National Cancer Institute (NCI) Clinical
